Shares of Sequenom have risen sharply for the fourth week in a row, climbing 11.5 percent for the five-day trading period ended Tuesday to lead all stocks in the BCW Index. Sequenom’s shares have doubled over the past month as the firm in-licensed rights to a next-generation sequencing technology and launched a new assay design and validation service.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.